Literature DB >> 21937747

Approach to neonatal seizures.

Lalitha Sivaswamy1.   

Abstract

Neonatal seizures can be difficult to recognize given the variation in their presentation. Hence, diagnosis and appropriate treatment may be delayed. Morphology of seizures in this age group is discussed, followed by common etiological entities. Special emphasis is laid on treatable disease states such as vitamin responsive seizure disorders and benign conditions that may not warrant aggressive treatment. Conditions that may have devastating neurological consequences are discussed in some detail so that the treating pediatrician can provide realistic information to the parents of such newborns. Imaging and laboratory workup is outlined, followed by guidelines for ordering and interpreting an electroencephalogram in this age group. Finally, treatment options in the form of antiepileptics are discussed with mention of new avenues for diagnosis and treatment that may become commonly employed in the future.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937747     DOI: 10.1177/0009922811419496

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  3 in total

1.  A Descriptive Study on the Neonatal Morbidity Profile of Autism Spectrum Disorders, Including a Comparison with Other Neurodevelopmental Disorders.

Authors:  H Ó Atladóttir; D E Schendel; E T Parner; T B Henriksen
Journal:  J Autism Dev Disord       Date:  2015-08

2.  Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures.

Authors:  N L Maitre; C Smolinsky; J C Slaughter; A R Stark
Journal:  J Perinatol       Date:  2013-09-19       Impact factor: 2.521

3.  Brain CT Scan, Sonography and EEG Findings in Neonates with Seizure.

Authors:  Mirhadi Mussavi; Shokoufeh Khanzadeh; Shahram Sadeghvand; Eslam Hasanpour; Morteza Akbari; Shahram Nasiri; Fateme Valaei
Journal:  Iran J Child Neurol       Date:  2022-07-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.